Global Deoxyribonucleic Acid (DNA) Vaccines Market is valued at USD 4.55 Billion in 2021 and is projected to attain a value of USD 11.43 Billion by 2028 at a CAGR of 7.2% during the forecast period, 2022–2028. Deoxyribonucleic Acid (DNA) Vaccines are made up of deoxyribonucleic acid (DNA), which encodes antigens and generates a broader variety of immune responses in the body with minimal adverse effects. The Deoxyribonucleic Acid (DNA) Vaccines approach involves delivering the gene to cells, which then expresses the gene and produces the desired protein.
Factors such as the growing population, the need to expand healthcare access, the rising prevalence of chronic diseases and conditions, a physician shortage, advancements in telecommunications, government support, increasing awareness, and increasing technology adoption are all driving growth in the Deoxyribonucleic Acid (DNA) Vaccines Market.
To have a better understanding of the report’s structure, download a PDF sample copy: https://www.vantagemarketresearch.com/deoxyribonucleic-acid-dna-vaccines-market-1264/request-sample
Rising Demand for Effective Treatment of Infectious Disease is Driving Market Growth
Increase in the number of cases of HIV, cancer, hepatitis, and other diseases, as well as an increase in government investment in Deoxyribonucleic Acid (DNA) Vaccines and an increase in the number of antibiotic-resistant pathogens have created the need for effective and low-cost vaccination, which are among the major factors driving the Deoxyribonucleic Acid (DNA) Vaccines Market. Deoxyribonucleic Acid (DNA) Vaccines are used to destroy and stop germs from growing.
The Global Deoxyribonucleic Acid (DNA) Vaccines Market can be segmented by Application, into Human Diseases, Veterinary Diseases Allergies and Others. On the basis of Type, the Deoxyribonucleic Acid (DNA) Vaccines Market is segmented into Human DNA Vaccines and Animal DNA Vaccines. Based on Region, the Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Some of the players are Inovio Biomedical Corp, Merck & Co., Mitsubishi Tanabe, Dendreon Corporation, ASTELLAS PHARMA, Dynavax Technologies, Sanofi, Tekmira Pharmaceuticals GlaxoSmithKline Corp, Protein Sciences Corp.among others.
Read Full Report: https://www.vantagemarketresearch.com/industry-report/deoxyribonucleic-acid-dna-vaccines-market-1264
About the Authors:
Vantage Market Research is a firm dedicated to delivering high-quality data and market research. The firm offers quantitative, high-quality B2B research on over 20,000 emerging markets. The firm provides in-depth reports on a variety of industries, including chemical materials and energy, food and drinks, healthcare, technology, and so on. Every year, the organisation adds more than 1,100 market research papers to its huge database, which employs over 125 analysts and consultants. The company’s customer includes 70% of the Fortune 500 corporations in the world.
6218 Georgia Avenue NW Ste 1 – 564 Washington, DC 20011-5125 Phone: +1 (202) 380-9727 Toll Free Number: +1 (877) 500-9070 Email: firstname.lastname@example.org
PR-Wirein, Reportedtimes, iCN Internal Distribution, Extended Distribution, Research Newswire, English